NT
Neobe Therapeutics
United Kingdom · Biotech · Healthtech
Neobe Therapeutics develops engineered bacterial medicines intended to help cancer drugs and immune cells reach solid tumours.
Product
Neobe Therapeutics develops programmable bacterial therapeutics designed to change the microenvironment around solid tumours. Its approach aims to remove physical barriers that can keep immune cells and existing cancer drugs from reaching their targets.
The company is advancing a preclinical pipeline and works from Stevenage Bioscience Catalyst in the United Kingdom. Its research focuses on enabling immunotherapy in cancers that exclude immune cells.
Funding history
2 rounds · 2 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $6.8M | ARC Ventures — Lead2048 Ventures — ParticipantEmpirical Ventures — ParticipantFaber — ParticipantMacmillan Ventures — ParticipantProven Connect — Participant | |
| Early-stage financing | $2.3M | 2048 Ventures — LeadPioneer Group — LeadCancer Research Horizons — ParticipantDeep Science Ventures — ParticipantDiscovery Park Ventures — ParticipantInnovate UK — ParticipantNadav Rosenberg — Participant |
Investors
ARC VenturesLed Seed2048 VenturesJoined Seed · Led Early-stage financingEmpirical VenturesJoined SeedFaberJoined SeedMacmillan VenturesJoined SeedProven ConnectJoined SeedPioneer GroupLed Early-stage financingCancer Research HorizonsJoined Early-stage financingDeep Science VenturesJoined Early-stage financingDiscovery Park VenturesJoined Early-stage financingInnovate UKJoined Early-stage financingNadav RosenbergJoined Early-stage financingCoverage
Nov 10, 2026Neobe Therapeutics · SeedFeb 29, 2024Neobe Therapeutics · Early-stage financingSimilar companies
BMBoston Medical SciencesBoston Medical Sciences develops AI-assisted colorectal cancer screening technology.¥5.6B · Series B
SSSunlit SeedlingsSunlit Seedlings measures biodiversity and microbial activity to help organisations assess and redesign ecosystems.Undisclosed · Corporate investment
BiomatterBiomatter designs custom enzymes for pharmaceutical, diagnostic, agricultural and industrial applications.$18M · Series A